Klinischer Nutzen intraläsionaler Methotrexat-Infiltration zur Unterscheidung kraterförmiger keratinozytärer Tumoren vor chirurgischem Eingriff
J Dtsch Dermatol Ges
.
2022 Jan;20(1):102-105.
doi: 10.1111/ddg.14637_g.
[Article in German]
Authors
Rafael Salido-Vallejo
1
2
,
Juan Luis Sanz-Cabanillas
2
,
Jorge María Núñez-Córdoba
3
,
Alberto González-Menchen
4
,
Antonio Vélez
2
,
Pedro Redondo
1
Affiliations
1
Department of Dermatology, University Clinic of Navarra, School of Medicine, University of Navarra, Pamplona, Spanien.
2
Department of Dermatology, Reina Sofía University Hospital, Córdoba, Spanien.
3
Research Support Service, Central Clinical Trials Unit, University Clinic of Navarra, Pamplona, Spanien.
4
Department of Pathology, Reina Sofía University Hospital, Córdoba, Spanien.
PMID:
35040574
DOI:
10.1111/ddg.14637_g
No abstract available
Publication types
Letter